Somatuline Autogel Injection
Lanreotide
60mg
IPSEN PHARMA
| Pack size | 1 Pre-filled Syringe |
|---|---|
| Dispensing mode | POM |
| Source | FRANCE |
| Agent | MEDICAL SCIENTIFIC EST. |
| Retail Price | 4547.00 AED |
Available as:
Indications
Somatuline Autogel Injection is used for:
Lanreotide is a somatostatin analog approved for treatment of neuroendocrine tumours and acromegaly. (2)
Adult Dose
Child Dose
Renal Dose
Administration
Contra Indications
Precautions
Pregnancy-Lactation
Interactions
Adverse Effects
Side effects of Lanreotide :
Mechanism of Action
Lanreotide is a somatostatin analogue (SSA) and has mainly inhibitory effects which are mediated via somatostatin receptors (SSTRs) 2 and 5 and include inhibition of growth hormone release in the brain. Tumor SSTR activation induces downstream cell cycle arrest and/or apoptosis, and also results in blunted production of substances that support tumor growth as well as tumor angiogenesis. This leads to the anti-proliferative effects of Lanreotide. (3)
Note
Somatuline Autogel 60mg Injection manufactured by IPSEN PHARMA. Its generic name is Lanreotide. Somatuline Autogel is availble in United Arab Emirates.
Farmaco UAE drug index information on Somatuline Autogel Injection is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.